Epidemiology, Drug Resistance, and Virulence of Staphylococcus aureus Isolated from Ocular Infections in Polish Patients by KŁOS, MARTA et al.
Polish Journal of Microbiology
2019, Vol. 68, No 4, 541–548
https://doi.org/10.33073/pjm-2019-056
ORIGINAL PAPER
* Corresponding author: J. Wójkowska-Mach, Department of Microbiology, Jagiellonian University Collegium Medicum, Kraków, Poland; 
e-mail: jadwiga.wojkowska-mach@uj.edu.pl
© 2019 Marta Kłos et al.
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License (https://creativecommons.
org/licenses/by-nc-nd/4.0/).
Introduction
Bacteria are considered as the main contributor 
to ocular infections all over the world (Teweldeme-
dhin et al. 2017). In the study by Long et al. conducted 
between 1990–2009, the most frequently isolated bac-
teria from ocular infections were Gram-positive cocci 
(41.9%) (Long et al. 2014). Analysis of databases proved 
that Staphylococcus aureus (SA) is predominant regard-
less of the geographical area or population examined 
(Teweldemedhin et al. 2017). The results of the research 
regarding the prevalence of SA isolates from ocular 
infections showed their distribution in the range from 
13% in India to 28.1% in Ethiopia; the average preva-
lence was 20.1% (Teweldemedhin et al. 2017).
The most common ocular infection is conjunctivi-
tis, which constitutes 50–70% of infectious conjuncti-
vitis (Bertino 2009; Galvis et al. 2014; Teweldemedhin 
et al. 2017). Moreover, one should also point out the 
frequent incidents of bacterial keratitis and endo-
phthal mitis (West et al. 2005; Bertino 2009; Pozzi et al. 
2012; Teweldemedhin et al. 2017). Untreated ocular 
infections may cause injuries in the ocular structure 
and lead to visual impairments and blindness (Bertino 
2009; Teweldemedhin et al. 2017). Researchers indicate 
a strong relationship between ocular trauma, contact 
lenses, and bacterial keratitis lesions in the anatomi-
cal ocular surface that may lead to the development of 
staphylococcal infection (Bourcier et al. 2003; Ly et al. 
2006; Teweldemedhin et al. 2017). Moreover, a patient’s 
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A b s t r a c t
Analysis of the epidemiology of Staphylococcus aureus (SA) ocular infections and virulence factors of the isolates with a special emphasis 
on their drug resistance, and the ability of biofilm formation. In a period from 2009 to 2013, 83 isolates of SA were prospectively col-
lected and preserved in a multicenter laboratory-based study carried out in southern Poland. Epidemiological, phenotypic, and genotypic 
analyses were performed. The resistance and virulence genes were analyzed. Screening for the biofilm formation was provided. Among the 
materials derived from ocular infections from 456 patients, SA was found in 18.2% (n = 83) of cases (one SA isolate per one patient). Most 
infections were identified in the age group of over 65 years (OR 8.4 95%CI; 1.03-68.49). The majority of patients (73.4%) were hospitalized. 
Among the virulence and resistance genes, the most frequently detected were the lukE (72.2%, n = 60) and ermA (15.6%, n = 13) genes. 
A positive result of the CRA test (the ability of biofilm formation) was found in 66.2% (n = 55) of isolates. Among the strains under study, 
6.0% (n = 5) had the methicillin-resistant Staphylococcus aureus phenotype, and 26.5% (n = 22) had the macrolide-lincosamide-strepto-
gramin B phenotype. In 48 (57.8%) isolates the neomycin resistance was revealed. All isolates under study were sensitive to vancomycin. 
The population most susceptible to ocular SA infections consists of hospitalized patients aged 65 and more. The SA strains under study 
showed the increased ability to biofilm formation. In the strains tested, high susceptibility to chloramphenicol and fluoroquinolones was 
demonstrated. However, the high level of drug resistance to neomycin detected in this study among SA isolates and the blood-ocular bar-
rier makes it difficult to treat ocular infections.
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immunity to ocular infections can be reduced by under-
lying diseases, operative procedures, the use of corticos-
teroids, hospitalization, and the use of medical devices 
(Teweldemedhin et al. 2017).
One of the main SA virulence factors that contrib-
ute to ocular infections is its ability to the formation of 
biofilms on the surface of biomedical implants or con-
tact lenses (Cramton et al. 1999). Through this process, 
the bacteria become more resistant to various physico-
chemical stresses, e.g. antibiotics (Mathur et al. 2018). 
Cramton and coworkers reported that SA was more 
frequently isolated from corneal infections related to 
the contact lenses wearing (Cramton et al. 1999). The 
extended wear of contact lenses and lack of eye hygiene 
increase the risk of keratitis. The morbidity of ocular 
infections is associated with the increasing number 
of cataract surgery and lens replacement (Astley et al. 
2019). The ability of SA strains to aggregate and form 
biofilm is related to their capacity of producing slime 
– an extracellular mucoid substance whose main com-
ponents are glycosaminoglycans. The well-established 
phenotypic methods, such as the Congo Red Agar 
(CRA) test, are still used for the identification of the 
virulent biofilm-forming bacteria confirming pheno-
typically their ability to develop a biofilm. It has been 
shown that the results of this method coincide with the 
presence of the icaA and icaD genes in staphylococci 
(Arciola et al. 2002).
There is little information on human SA ocular infec-
tions in databases such as PubMed, a fact that makes 
it impossible to work out and implement effective and 
plausible measures to prevent infections. Concerning 
Polish patients, there is no epidemiological data at all. 
We sought to describe the epidemiology and various 
types of treatment for SA ocular infections with a spe-
cial emphasis on cataract postoperative complications 
or the consequences of soft contact lenses wearing.
Experimental
Materials and Methods
SA isolates. Isolates from this multicenter labora-
tory-based study were obtained by the Department 
of Microbiology of the Jagiellonian University Medi-
cal College and were collected in collaboration with 
KORLAB from 1 January to 31 December 2013. Non-
repetitive samples from ocular infection were col-
lected from hospitalized patients (62) or outpatients 
(21) throughout the south of Poland. In total, clinical 
materials from 456 patients with symptoms of infec-
tion were examined and 83 isolates of SA were found, 
including 47 strains from the vitreous and corneas. The 
remaining clinical materials were conjunctival swabs. 
The relevant patient information including age, sex, and 
type of care (ambulatory/hospitalization) was collected. 
The identification of microorganisms was performed 
using the MALDI-TOF Biotyper (Bruker Corporation, 
the Netherlands) according to standard methods.
Susceptibility testing. Antimicrobial susceptibil-
ity testing of all SA isolates was performed according 
to the current guidelines of the European Committee 
on Antimicrobial Susceptibility Testing (EUCAST, 
http://www.eucast.org/clinical_breakpoints/; accessed 
December 2017) by disc diffusion or the E-test method 
on Müeller-Hinton agar plates. The antimicrobial discs 
(Oxoid Ltd., UK) contained gentamicin (10 µg), ami- 
ka cin (30 µg), tobramycin (10 µg), neomycin (10 µg), 
cipro floxacin (5 µg), moxifloxacin (5 µg), trimetho-
prim/sulfamethoxazole (1.25/23.75 µg), clindamycin 
(2 µg), erythromycin (15 µg), chloramphenicol (30 µg), 
and tetracycline (30 µg). Antimicrobial susceptibility to 
neomycin was interpreted according to the standards 
of the British Society for Antimicrobial Chemotherapy 
Version 14.0, 05.01.2015 (BSAC, http://bsac.org.uk/wp-
content/uploads/2012/02/BSAC-Susceptibility-testing-
version-14.pdf). For vancomycin, the minimal inhibi-
tory concentration (MIC) was determined by E-test 
(bioMérieux, France).
The methicillin-resistant Staphylococcus aureus 
(MRSA) phenotype was detected using a cefoxitin disc 
(30 μg). The macrolide-lincosamide-streptogramin  B 
(MLSB) phenotype was determined according to a pre-
viously published protocol (Leclercq 2002).
The categories of antimicrobial resistance. Strains 
were divided into six categories based on their resist-
ance to several antimicrobial agent categories (amino-
glycosides, fluoroquinolones, folate pathway inhibitors, 
lincosamides, macrolides, phenicols, and tetracyclines). 
The susceptibility of the isolate to all antimicrobial 
agents from all categories examined denoted “0”; “5 or 
more” meant resistance to five or more categories.
DNA isolation. The bacterial strains were grown 
overnight at 37°C in tryptic soy broth medium and total 
DNA was isolated with the Genomic Mini Kit (A&A 
Biotechnology, Gdynia, Poland) according to the manu-
facturer’s instructions.
Polymerase Chain Reaction (PCR)-based detec-
tion of resistance and virulence genes. PCR amplifica-
tion was used to detect the mecA gene using previously 
described primers (Pereira et al. 2010). As controls, SA 
ATCC 33591 (mecA+) and SA ATCC 25923 (mecA−) 
were employed. PCR was also used to detect the pres-
ence of a gene resistant to mupirocin (mupA gene) 
(Anthony et al. 1999). SA ATCC BAA-1708 (mupA+) 
was employed as a control. The erythromycin resistance 
genes (ermA, ermB, ermC, and msr) were detected by 
multiplex PCR (Sutcliffe et al. 1996). The bands were 
visualized with the UVP GelDocIT Imaging System 
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(UVP, Upland, Canada) after 1.5%-TBE-agarose elec-
trophoresis (70 min, 90 mV) and staining with ethidium 
bromide (Bio-Rad, Warsaw, Poland). A DNA-ladder of 
100–1000 bp (Thermo Scientific, Waltham, MA, USA) 
was used as a size marker.
SA isolates were verified for the presence of the fol-
lowing virulence genes: lukE (LukDE leukocidin), pvl 
(Panton-Valentine leukocidin, PVL), tsst-1 (toxic shock 
syndrome toxin-1, TSST-1), etA, and etB (exfoliative 
toxin A or B; EtA, EtB) using PCR and the previously 
described primers (Johnson et al. 1991; Lina et al. 1999). 
The strains used as controls were kindly provided by 
Prof. Marek Gniadkowski, National Medicines Institute, 
Warsaw, Poland.
To determine the spa type of the polymorphic 
X-region of the SA protein A, the spa gene was ampli-
fied by PCR and sequenced. Chromatograms obtained 
from sequencing were analyzed using DNAGear Spa 
Typing Software (Al-Tam et al. 2012).
Biofilm formation. Screening for the ability of SA 
isolates to develop a biofilm was carried out accord-
ing to the method described by Arciola et al. with the 
CRA test (Arciola et al. 2002). 0.8 g of Congo Red and 
36 g of saccharose (Sigma, St. Louis, MO, USA) were 
added to 1L of brain heart infusion agar (Oxoid, Bas-
ingstoke, Hampshire, England) to prepare CRA plates. 
The plates were incubated at 37°C for 24 h and then 
overnight at room temperature. On CRA plates, black 
colonies were formed by slime-producing strains and 
red ones by non-producing strains. A six-color scale 
was used to accurately assess all the possible chromatic 
variations exhibited by the growing colonies. The scale 
ranged from very black (vb), thorough black (b), and 
almost black (ab) to burgundy (brd), red (r), and very 
red (vr). Very black, black, and almost black colonies 
were classified as the slime producer strains, while very 
red, red, and burgundy-colored colonies were classified 
as the strains unable to produce slime.
Ethics. All SA isolates under the study were collected 
as part of routine clinical care. No medical records or 
identifying information about the patients were accessed 
as part of this study. The isolates and any relevant infor-
mation about the cases were obtained and analyzed in 
a  fully anonymized and de-identified form. All data 
analyzed during this study were blinded before analysis. 
The utilization of this data for analysis without patients’ 
agreement was consistent with Polish law and approved 
by the Bioethics Committee of the Jagiellonian Univer-
sity Medical College (No. BET/227/B/2012).
Results
Among the 456 cases of ocular infections exam-
ined, 83 (18.2%) SA strains were isolated (one strain 
from one patient). Slightly more than half of SA strains 
(54.2%) came from men. The majority of patients, i.e. 
73.4% (42.6% of women and 57.3% of men, respec-
tively) constituted the hospitalized cases (Table I). The 
results showed a large difference in SA-ocular infec-
tion prevalence between hospitalized and ambulatory 
patients. The most infection cases were observed in 
the group of people over 65 years (63.8%); the least in 
the biggest group of age in the range between 19 and 
64 years (16.8%). The infections in the oldest patients 
were treated five times more often in an outpatient set-
ting (OR 95%CI 8.4; 1.03-68.49; p = 0.027, Table I).
One of the virulence characteristics, which is biofilm 
formation, was evaluated with the CRA test. A positive 
result of the CRA test was found in 66.2% of all cases 
(Table I). It was demonstrated that 66.2% of the strains 
showed biofilm formation capacity, with 22% of them 
Age (years) by categories [n; %]
< = 18 years 15 (24.5%)  1 (4.5%) 16 (19.2%) 2.5 (0.20–32.99)
19–64 years 12 (19.6%)  2 (9.0%) 14 (16.8%) 1.00 (ref.) 0.027
> = 65 years 34 (55.7%) 19 (86.3%) 53 (63.8%) 8.4 (1.03–68.49)
Gender [n; %]
Female 26 (42.6%) 12 (54.5%) 38 (45.7%) 
0.6 (0.23–1.65) 0.454
Male 35 (57.3%) 10 (45.4%) 45 (54.2%)
The positive CRA (Congo Red Agar) biofilm test result (n; %)
yes 45 (73.7%) 10 (45.4%) 55 (66.2%) 
3.3 (1.22–9.31) 0.016
no 16 (26.2%) 12 (54.5%) 28 (33.7%)
Table I
Staphylococcus aureus strains isolated from ocular infections in different patient age groups with consideration
of gender, hospitalization, and the results of the CRA test.
OR (95%CI) – 95% confidence intervals of the odds ratio
Characteristics
of the study group
Hospitalization (n; %)
Total, N = 83
OR (95% CI) p-value
Yes, n = 61 (73.4%) No, n = 22 (26.5%)
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being strong biofilm formers (very black and black 
colors), and 44% being weaker (almost black color). 
Among the biofilm-forming strains, the hospital strains 
dominated (73.4%), whereas among the ambulatory 
strains the ratio between biofilm-forming strains and 
non-producing ones was more even (45.4% vs. 54.5%; 
OR 95%CI 3.3; 1.22–9.31; p = 0.016, Table I).
The most frequent virulence and resistance genes 
were lukE and ermA (Table II). The presence of other 
virulence genes oscillated within the range of 1.2–12.0% 
of cases. The pvl gene was found in one strain. Strains 
from hospitalized patients were the main source of vir-
ulence genes. In the isolates from ambulatory patients, 
the mup, tsst-1, pvl or etB genes were not found. Inter-
estingly, all cases of the pvl, tsst and etB genes detected 
in this study as well as two out of three the etA genes 
and 63% of the lukE genes were found among the 
strains positive in the CRA test.
Among the SA strains, most were resistant to neomy-
cin and comprised 57.8% (n = 48). The level of erythro-
mycin resistance amounted to 25.3%; 13.2% of isolates 
were resistant to ciprofloxacin, and 7.2% to moxifloxacin 
(Table III). Resistance to fluoroquinolones was five times 
more often found in ambulatory patients. Additionally, 
resistance to tobramycin was recorded for 14  strains 
(16.8%), to gentamicin for five strains (6.0%), and to 
chloramphenicol also for five strains (6.0%). All the 
isolates under study were sensitive to vancomycin, and 
the MIC value was equal to 1 µg/ml. Out of the isolates 
under study, 73.4% belonged to the category of fully sus-
ceptible to antimicrobial agents. The highest percentage 
of strains resistant to at least one antimicrobial was iden-
tified in hospitalized patients (40.9% for one category) 
and in outpatients (27.2% for two categories) (Table III). 
On the other hand, the strains isolated from hospitalized 
patients were four times more likely to show full suscep-
tibility (they belonged to the “fully susceptible” category, 
Table III) than strains from non-hospitalized patients.
Among the strains under study, five isolates (6.0%) 
had the MRSA phenotype and 22 had the MLSB pheno- 
type (26.5%), including 17 strains that had the induc-
ible (iMLSB) and five strains that had the constitutive 
(cMLSB) phenotypes (Table III). Four strains mani-
fested both mechanisms at the same time. Each of the 
five MRSA strains had the mecA gene. Additionally, one 
strain had the mecA gene without the MRSA phenotype. 
Thirteen strains contained the ermA gene, including 
all those with the mechanism of cMLSB resistance and 
seven with that of iMLSB. One strain with the iMLSB 
mechanism had the msrA/B gene, and in eight strains 
none of the genes of resistance under study was found.
Spa typing of five MRSA isolates showed the pres-
ence of three different spa types – three strains belonged 
to t003, one to t015, and one to t1192.
Discussion
In the studied population, the contribution of SA 
strains to ocular infections was slightly higher than in 
the American population as it has been shown by Gen-
tile and coworkers, and where the most prevalent patho - 
gens were coagulase-negative staphylococci (39.4%), 
followed by Streptococcus viridans (12.1%), and SA 
(11.1%) (Gentile et al. 2014). Similar findings came 
from Canada and Europe (Asencio et al. 2014; Assaad 
et al. 2015). A Chinese analysis of corneal samples 
have provided that Gram-positive cocci (69.88%) are 
the most commonly isolated; nevertheless, a decreas-
ing trend was observed over the nine years of the study 
(Lin et al. 2019).
However, despite its non-dominant role in ocular 
infections, SA is an important etiologic agent of ocu-
lar infections. Callegan and coworkers have reported 
that ocular SA infections were more difficult to treat 
and the sharpness of vision was restored only in 30% 
mecA (n = 6; 7%)  4 (6.5%)  2 (9.0%)  6 (7.2%)
ermA (n = 13; 16%)  8 (13.1%)  5 (22.7%) 13 (15.6%)
mup (n = 4; 5%)  4 (6,5%)  0  4 (4.8%)
lukE (n = 60; 72%) 45 (73.7%) 15 (68.1%) 60 (72.2%)
tsst-1 (n = 10; 12%) 10 (16.3%)  0 10 (12.0%)
etA (n = 3; 4%)  2 (3.2%)  1 (4.5%)  3 (3.6%)
etB (n = 2; 2%)  2 (3.2%) N0  2 (2.4%)
Table II
The presence of various genes encoding for the resistance and virulence factors of 
Staphylococcus aureus strains isolated from ocular infections.
etA/B – exfoliative toxin A and/or B; lukE – lukDE leukocidins; N/A – not applicable;
OR (95%CI) – 95% confidence intervals of odds ratio
Studied genes
Hospitalization (n;%)
Total n = 83
Yes, n = 61 (73.4%) No, n = 22 (26.5%)
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of the patients (Callegan et al. 2007). The research con-
ducted by West and coworkers from 1994 to 2001 in 
the American population has indicated an increase in 
endophthalmitis incidence as a complication of cataract 
surgery, a fact that is challenging because this was the 
most common surgery in the USA (West et al. 2005; 
Astley et al. 2019). The reports by West and coworkers 
were confirmed by the results of Callegan and cowork-
ers, which showed that postoperative endo phthalmitis 
was a result of almost every ocular surgery, mainly 
cataract surgery (Callegan et al. 2007). Astley and cow-
orkers also pointed to an increase in injection-related 
complications following intravitreal injections (Astley 
et al. 2019). One of the important elements that inter-
fere with proper postoperative healing, and is the cause 
of therapeutic failures can be the virulence of patho-
gens. In any operation with the use of implants, such 
as cataract surgery, SA can present its capacity to form 
a  biofilm. This problem was discussed by Ammen-
dolia and coworkers who demonstrated the presence 
of a very high proportion of biofilm-forming strains 
(88.9%) higher than in the population investigated here 
(66.2%) (Ammendolia et al. 1999). At the same time, 
Ammendolia and coworkers has initially claimed that 
slime production was never considered as a virulence 
factor, but their studies generally dealt with various 
types of hospital infections, not only ocular infections 
(Ammendolia et al. 1999). The studies considering the 
problem of biofilm-forming strains in ocular infections, 
however, have not been conducted so far. Atshan and 
coworkers have indicated the biofilm formation to var-
ied extent and diverse adherence capacities of MRSA 
strains depending on their spa type (Atshan et al. 2012).
The results from the Antibiotic Resistance Monitor-
ing in Ocular Microorganisms (ARMOR) group have 
shown that of MRSA amounts to 39% of ocular infec-
tions and there is also an increase in the resistance to 
fluoroquinolones among the ophthalmic strains in the 
United States (Haas et al. 2011; Vola et al. 2013). This 
was confirmed by a study by Morrissey and cowork-
ers conducted in European countries, where MRSA 
was shown to be an etiologic agent of 22% of all ocular 
SA infections (Morrissey et al. 2004; Vola et al. 2013). 
Fortunately, according to the data analyzed and pre-
sented here, the problem of MRSA does not concern 
southern Poland since the prevalence of MRSA is lower. 
The authors’ previous experience regarding other clini-
cal forms of both hospital and outpatient infections in 
southern Poland indicated a high prevalence of MRSA 
in bloodstream infections (20.4%), and pneumonia 
 Gentamicin  4 (6.5%)  1 (4.5%)  5 (6.0%)
Aminoglycosides Amikacin  5 (8.1%)  3 (13.6%)  8 (9.6%)
 Tobramycin  9 (14.7%)  5 (22.7%) 14 (16.8%)
 Neomycin 37 (60.6%) 11 (50.0%) 48 (57.8%)
Fluoroquinolones
 Ciprofloxacin  4 (6.5%)  7 (31.8%) 11 (13.2%)
 Moxifloxacin  2 (3.2%)  4 (18.1%)  6 (7.2%)
Folate pathway inhibitors Trimethoprim/sulfamethoxazole  3 (4.9%)  2 (9.0%)  5 (6.0%)
Lincosamides Clindamycin 13 (21.3%)  8 (36.3%) 21 (25.3%)
Macrolides Erythromycin 13 (21.3%)  8 (36.3%) 21 (25.3%)
Phenicols Chloramphenicol  4 (6.5%)  1 (4.5%)  5 (6.0%)
Tetracyclines Tetracycline 11 (18.0%) 3 (13.6%) 14 (16.8%)
Non-susceptible to antimicrobial agents in (above) categories
 fully susceptible (0 categories) 37 (60.6%)  6 (27.2%) 61 (73.4%)
 one category 25 (40.9%)  4 (18.1%) 29 (34.9%)
 2 categories 12 (19.6%)  6 (27.2%) 18 (21.6%)
 3 categories  5 (8.1%)  1 (4.5%)  6 (7.2%)
 4 categories  2 (3.2%)  1 (4.5%)  3 (3.6%)
 5 categories or more  2 (3.2%)  4 (18.1%)  5 (6.0%)
MRSA, yes   3 (4.9%)  2 (9.0%)  5 (6.0%)
MLSB, yes   14 (22.9%)  8 (36.3%) 22 (26.5%)
Table III
Drug resistance of Staphylococcus aureus strains isolated from ocular infections.
MLSB – macrolide/lincosamide/streptogramin B resistant Staphylococcus aureus; MRSA – methicillin-resistant Staphylococcus aureus; 





Yes, n = 61 (73.4%) No, n = 22 (26.5%)
Total, N = 83
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(32.7%) (Pomorska-Wesołowska et al. 2017). The gen-
eral hospital prevalence of MRSA is 15.1%, and it is 
three times higher than it was established in the recent 
ocular infection study (Chmielarczyk et al. 2016). As 
reported previously, and also in this study, the spa typ-
ing confirmed that spa type t003 was the most predom-
inant among MRSA strains (Chmielarczyk et al. 2016; 
Pomorska-Wesołowska et al. 2017).
Between the above-mentioned studies and ours, 
there was no difference in SA resistance to MLSB, 
which was observed at a similar level (less than 30% 
in the studied patients’ population with ocular infec-
tions) as well as in other populations of patients in 
southern Poland (Chmielarczyk et al. 2016; Pomorska-
Wesołowska et al. 2017). Unfortunately, there are no 
known reports on MLSB resistance in ocular infections 
coming from other parts of the world.
The most common antibiotics administered in ocu-
lar infections are fluoroquinolones, chloramphenicol, 
and aminoglycosides (Brown 2007). Unluckily, both 
Polish data and evidence from other centers, including 
those from Europe, indicate a low sensitivity of SA to 
aminoglycosides and some fluoroquinolones (Galvis 
et al. 2014; Gentile et al. 2014). Nevertheless, in the lat-
est ARMOR surveillance studies from the USA, there 
was no difference in the level of resistance to older- 
(ciprofloxacin) and newer-generation fluoroquinolones 
(moxifloxacin), and it was 35.8% vs 33.6%, respectively. 
In our study, resistance was lower to moxifloxacin 
(7.2%) than to ciprofloxacin (13.2%), so the newer 
generation of fluoroquinolones can be more effective 
in therapy (Thomas et al. 2019).
Given the rising resistance of 4th generation fluo-
roquinolones that have been observed in recent years, 
researches were conducted on the effectiveness of 
aminoglycosides (Galvis et al. 2014). Chinese research 
on corneal infections caused by SA confirmed the 
lowest resistance of the strains to neomycin (Wang et al. 
2016). The possibility of treatment with the aminogly-
coside group was confirmed independently by stud-
ies by Blanco and coworkers and Lin and coworkers, 
which showed high susceptibility of those strains to 
chloramphenicol (Blanco et al. 2013; Lin et al. 2019). 
Our results also confirm the high susceptibility of the 
SA isolates to fluoroquinolones and chloramphenicol. 
This is important information because the results of 
systematic review and meta-analysis suggested that 
fluoroquinolones might be the first choice for empiri-
cal treatment of most cases of the suspected bacterial 
keratitis (Hanet et al. 2012; Austin et al. 2017).
Unfortunately, the findings of this study have indi-
cated that in Poland a serious problem, rarely described 
by other authors, occurs i.e. the resistance of SA to neo-
mycin in almost 60% of strains. It appears that this is 
quite a rare situation because the reports of Wang and 
coworkers from China have recently determined neo-
mycin resistance in 7.8% of strains, i.e. at a consider-
ably lower level than that established for the isolates 
from Polish patients (Wang et al. 2016). Therefore, this 
situation is surprising as neomycin is not frequently 
or routinely used systemically in the treatment of more 
common infections as opposed to ocular infections. All 
pharmaceutical preparations with neomycin associated 
with ocular treatment are available in Poland on pre-
scription and none of them is a combined preparation. 
For the topical dermatological treatment, there are avail-
able over-the-counter medicines containing neomycin 
in combination with e.g. bacitracin, which could lead 
to such high neomycin resistance but the lack of Polish 
historical data or data from other countries makes it 
difficult to interpret the phenomenon observed.
Ocular antibiotics are usually administered locally, 
in the form of solution or suspension, to obtain a high 
concentration of antibacterial in the place of infection. 
Since the 1980s, the antibiotics can be administered in 
the form of injections directly into the vitreous, with the 
visual outcome of patients not changed considerably 
(Callegan et al. 2007). In ocular infections, therapeutic 
success depends on quick and accurate diagnosis and 
also on the administration of antibiotics (Callegan et al. 
2007). This is due to the bacterial toxins and enzymes 
that may damage the integrity of the ocular tissues 
(Bertino 2009). Astley and coworkers reported some 
of those, including α-toxin (a role in the pathogenesis of 
SA keratitis and endophthalmitis) and PVL (cytotoxin) 
(Astley et al. 2019). The key anatomic barriers, such as 
the delicate nature of the interior of the eye and the 
blood-ocular barrier are factors to be considered during 
treatment (Callegan et al. 2007). Drug administration 
and contact lenses consist of a problem.
Study limitations
There are some limitations associated with this labo-
ratory-based study. First, the demographic information 
on the study population is limited. For example, previ-
ous hospitalization and/or surgery and antimicrobial 
usage, co-morbidity, disability, and patient outcome 
data were not available because of the retrospective 
nature of the study. Additionally, these results may not 
be generalizable to the other parts of Poland.
Conclusions
In conclusion, the most common microorganisms in 
ocular infections were Gram-positive cocci, especially 
SA strains. The main virulence factor was the biofilm 
formation capacity of isolates and a high percentage of 
Staphylococcus aureus ocular infections4 547
strains with the lukE gene was also observed. Although 
high resistance to neomycin was noted, our research 
indicates a high efficacy of treatment with chloram-
phenicol and fluoroquinolones, as well as the need to 
implement new solutions due to the aforementioned 
bacteria’s high resistance to neomycin and anatomic 
barrier difficulties.
Funding
This work was supported by the grants from Jagiellonian Uni-
versity Medical College ZDS/007045 and SAP N43/DBS/000014.
Acknowledgments
We would like to thank Professor Marta Wałaszek for help in 
statistical analysis.
Conflict of interest
The authors do not report any financial or personal connections 
with other persons or organizations, which might negatively affect 
the contents of this publication and/or claim authorship rights to 
this publication.
Literature
Al-Tam F, Brunel AS, Bouzinbi N, Corne P, Bañuls AL, Shah ba-
zkia HR. DNA Gear – a free software for spa type identification in 
Staphylococcus aureus. BMC Res Notes 2012;19(5):642.
Ammendolia MG, Di Rosa R, Montanaro L, Arciola CR, Baldas-
sarri L. Slime production and expression of the slime-associa ted 
antigen by staphylococcal clinical isolates. J Clin Microbiol. 1999 
Oct;37(10):3235–3238.
Anthony RM, Connor AM, Power EGM, French GL. Use of the 
polymerase chain reaction for rapid detection of high-level mupiro-
cin resistance in staphylococci. Eur J Clin Microbiol Infect Dis. 
1999 Feb 24;18(1):30–34. https://doi.org/10.1007/s100960050222
Arciola CR, Campoccia D, Gamberini S, Cervellati M, Donati E, 
Montanaro L. Detection of slime production by means of an opti-
mised Congo red agar plate test based on a colourimetric scale in 
Staphylococcus epidermidis clinical isolates genotyped for ica locus. 
Biomaterials. 2002 Nov;23(21):4233–4239.
https://doi.org/10.1016/S0142-9612(02)00171-0
Asencio MA, Huertas M, Carranza R, Tenías JM, Celis J, Gon-
zález-Del  Valle F. [Microbiological study of infectious endo-
phthal mitis with positive culture within a 13 year-period]. Rev Esp 
Quimioter. 2014 Mar;27(1):22–27.
Assaad D, Wong D, Mikhail M, Tawfik S, Altomare F, Berger A, 
Chow D, Giavedoni L. Bacterial endophthalmitis: 10-year review 
of the culture and sensitivity patterns of bacterial isolates. Can 
J Ophthalmol. 2015 Dec;50(6):433–437.
https://doi.org/10.1016/j.jcjo.2015.07.013
Astley R, Miller FC, Mursalin MH, Coburn PS, Callegan MC. 
An eye on Staphylococcus aureus toxins: roles in ocular damage and 
inflammation. Toxins (Basel) 2019;11(6):356.
https:doi.org/10.3390/toxins11060356
Atshan SS, Shamsudin MN, Thian Lung LT, Sekawi Z, Ghaznavi-
Rad E, Pei Pei C. Comparative characterisation of genotypically 
different clones of MRSA in the production of biofilms. J Biomed 
Biotechnol. 2012;2012:1–7. https://doi.org/10.1155/2012/417247
Austin A, Lietman T, Rose-Nussbaumer J. Update on the  manage- 
ment of infectious keratitis. Ophthalmology. 2017 Nov;124(11): 
1678–1689. https://doi.org/10.1016/j.ophtha.2017.05.012
Bertino JS Jr. Impact of antibiotic resistance in the management 
of ocular infections: the role of current and future antibiotics. Clin 
Ophth almol. 2009 Sep;3:507–521.
https://doi.org/10.2147/OPTH.S5778
Blanco AR, Sudano Roccaro A, Spoto CG, Papa V. Susceptibility 
of methicillin-resistant Staphylococci clinical isolates to netilmicin 
and other antibiotics commonly used in ophthalmic therapy. Curr 
Eye Res. 2013 Aug;38(8):811–816.
https://doi.org/10.3109/02713683.2013.780624
Bourcier T, Thomas F, Borderie V, Chaumeil C, Laroche L. Bac-
terial keratitis: predisposing factors, clinical and microbiological 
review of 300 cases. Br J Ophthalmol. 2003 Jul 01;87(7):834–838.
https://doi.org/10.1136/bjo.87.7.834
Brown L. Resistance to ocular antibiotics: an overview. Clin Exp 
Optom. 2007 Jul;90(4):258–262.
https://doi.org/10.1111/j.1444-0938.2007.00154.x
Callegan M, Gilmore M, Gregory M, Ramadan R, Wiskur B, 
Moyer A, Hunt J, Novosad B. Bacterial endophthalmitis: therapeu-
tic challenges and host–pathogen interactions. Prog Retin Eye Res. 
2007 Mar;26(2):189–203.
https://doi.org/10.1016/j.preteyeres.2006.12.001
Chmielarczyk A, Pomorska-Wesołowska M, Szczypta A, Roma-
niszyn D, Pobiega M, Wójkowska-Mach J. Molecular analysis of 
methicillin-resistant Staphylococcus aureus strains isolated from 
different types of infections from patients hospitalized in 12 regio-
nal, non-teaching hospitals in southern Poland. J Hosp Infect. 2017 
Mar;95(3):259-267. https://doi.org/10.1016/j.jhin.2016.10.024
Cramton SE, Gerke C, Schnell NF, Nichols WW, Götz F. The 
intercellular adhesion (ica) locus is present in Staphylococcus 
aureus and is required for biofilm formation. Infect Immun. 1999 
Oct;67(10):5427–5433.
Galvis V, Tello A, Guerra A, Acuña MF, Villarreal D. [Antibiotic 
susceptibility patterns of bacteria isolated from keratitis and 
intra ocular infections at Fundación Oftalmológica de Santander 
(FOSCAL), Floridablanca, Colombia]. Biomedica. 2014 Apr;34(1) 
Suppl 1:23–33.
Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, 
Davis A, Hu DN. Microbiological spectrum and antibiotic sen si-
tivity in endophthalmitis: a 25-year review. Ophthalmology. 2014 
Aug; 121(8):1634–1642.
https://doi.org/10.1016/j.ophtha.2014.02.001
Haas W, Pillar CM, Torres M, Morris TW, Sahm DF. Monito- 
ring antibiotic resistance in ocular microorganisms: results from 
the Antibiotic Resistance Monitoring in Ocular micRorganisms 
(ARMOR) 2009 surveillance study. Am J Ophthalmol. 2011 Oct; 
152(4):567–574.e3. https://doi.org/10.1016/j.ajo.2011.03.010
Hanet MS, Jamart J, Pinheiro Chaves A. Fluoroquinolones or 
fortified antibiotics for treating bacterial keratitis: systematic review 
and meta-analysis of comparative studies. Can J Ophthalmol. 2012 
Dec;47(6):493–499.
https://doi.org/10.1016/j.jcjo.2012.09.001
Johnson WM, Tyler SD, Ewan EP, Ashton FE, Pollard DR, Rozee 
KR. Detection of genes for enterotoxins, exfoliative toxins, and 
toxic shock syndrome toxin 1 in Staphylococcus aureus by the poly-
merase chain reaction. J Clin Microbiol. 1991 Mar;29(3):426–430.
Leclercq R. Mechanisms of resistance to macrolides and linco-
samides: nature of the resistance elements and their clinical impli-
cations. Clin Infect Dis 2002;34(4):482–492.
Lin L, Duan F, Yang Y, Lou B, Liang L, Lin X. Nine-year analysis 
of isolated pathogens and antibiotic susceptibilities of microbial 
keratitis from a large referral eye center in southern China. Infect 
Drug Resist. 2019 May;12(12):1295–1302.
https://doi.org/10.2147/IDR.S206831
Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gaudu- 
chon V, Vandenesch F, Etienne J. Involvement of Panton-Valentine 
Kłos M. et al. 4548
leukocidin-producing Staphylococcus aureus in primary skin infec-
tions and pneumonia. Clin Infect Dis. 1999 Nov 01;29(5): 1128–
1132. https://doi.org/10.1086/313461
Long C, Liu B, Xu C, Jing Y, Yuan Z, Lin X. Causative organisms 
of post-traumatic endophthalmitis: a 20-year retrospective study. 
BMC Ophthalmol. 2014 Dec;14(1):34.
https://doi.org/10.1186/1471-2415-14-34
Ly CN, Pham JN, Badenoch PR, Bell SM, Hawkins G, Raf- 
ferty DL, McClellan KA. Bacteria commonly isolated from keratitis 
spe cimens retain antibiotic susceptibility to fluoroquinolones and 
gen ta micin plus cephalothin. Clin Exp Ophthalmol. 2006 Jan; 
34(1): 44–50. 
https://doi.org/10.1111/j.1442-9071.2006.01143.x
Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP. Fighting 
biofilms with lantibiotics and other groups of bacteriocins. NPJ 
Biofilms Microbiomes. 2018 Dec;4(1):9.
https://doi.org/10.1038/s41522-018-0053-6
Morrissey I, Burnett R, Viljoen L, Robbins M. Surveillance of the 
susceptibility of ocular bacterial pathogens to the fluoroquinolone 
gatifloxacin and other antimicrobials in Europe during 2001/2002. 
J Infect. 2004 Aug;49(2):109–114.
https://doi.org/10.1016/j.jinf.2004.03.007
Pereira EM, Schuenck RP, Malvar KL, Iorio NLP, Matos PDM, 
Olendzki AN, Oelemann WMR, dos Santos KRN. Staphylococcus 
aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus: 
methicillin-resistant isolates are detected directly in blood cultures 
by multiplex PCR. Microbiol Res. 2010 Mar;165(3):243–249.
https://doi.org/10.1016/j.micres.2009.03.003
Pomorska-Wesołowska M, Chmielarczyk A, Chlebowicz M, Ziół-
kowski G, Szczypta A, Natkaniec J, Romaniszyn D, Pobiega M, 
Dzikowska M, Krawczyk L, et al. Virulence and antimicrobial resis - 
tance of Staphylococcus aureus isolated from bloodstream infec tions 
and pneumonia in Southern Poland. J Glob Antimicrob Resist. 
2017 Dec;11:100–104. https://doi.org/10.1016/j.jgar.2017.07.009
Pozzi C, Waters EM, Rudkin JK, Schaeffer CR, Lohan AJ, Tong P, 
Loftus BJ, Pier GB, Fey PD, Massey RC, et al. Methicillin resis-
tance alters the biofilm phenotype and attenuates virulence in Sta- 
phylococcus aureus device-associated infections. PLoS Pathog. 2012 
Apr 5;8(4):e1002626. https://doi.org/10.1371/journal.ppat.1002626
Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of 
erythromycin-resistant determinants by PCR. Antimicrob Agents 
Chemother. 1996 Nov;40(11):2562–2566.
https://doi.org/10.1128/AAC.40.11.2562
Teweldemedhin M, Gebreyesus H, Atsbaha AH, Asgedom SW, 
Saravanan M. Bacterial profile of ocular infections: a  systematic 
review. BMC Ophthalmol. 2017 Dec;17(1):212.
https://doi.org/10.1186/s12886-017-0612-2
Thomas RK, Melton R, Asbell PA. Antibiotic resistance among 
ocular pathogens: current trends from the ARMOR surveillance 
study (2009–2016). Clinical Optometry. 2019 Mar;11(11):15–26.
https://doi.org/10.2147/OPTO.S189115
Vola ME, Moriyama AS, Lisboa R, Vola MM, Hirai FE, Bispo PJM, 
Höfling-Lima AL. Prevalence and antibiotic susceptibility of methi - 
cillin-resistant Staphylococcus aureus in ocular infections. Arq Bras 
Oftalmol. 2013 Dec;76(6):350–353.
https://doi.org/10.1590/S0004-27492013000600006
Wang N, Huang Q, Tan YW, Lin LP, Wu KL. Bacterial spectrum 
and resistance patterns in corneal infections at a Tertiary Eye Care 
Center in South China. Int J Ophthalmol. 2016 Mar 18;9(3):384–389.
West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. 
The incidence of endophthalmitis after cataract surgery among 
the U.S. Medicare population increased between 1994 and 2001. 
Ophthalmology. 2005 Aug;112(8):1388–1394.
https://doi.org/10.1016/j.ophtha.2005.02.028
